Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for cure. A new study suggests that proteins detectable in the blood could improve predictions about risk of liver cancer years before typical diagnosis.